This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Find out more here.

eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
New eMC coming June 2013...

Alcon Laboratories (U.K) Limited

Frimley Business Park, Frimley, Camberley, GU16 7SR, UK
Telephone: (0)871 376 1402
Fax: +44 (0)1276 673971
Stock Availability: (0)871 376 0084

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?


Summary of Product Characteristics last updated on the eMC: 09/09/2013
SPC Tears Naturale


Go to top of the page
1. Name of the medicinal product

Tears Naturale


Go to top of the page
2. Qualitative and quantitative composition

Dextran 70 0.1% w/v

Hypromellose 0.3% w/v


Go to top of the page
3. Pharmaceutical form

Eye drops, solution.


Go to top of the page
4. Clinical particulars

Go to top of the page
4.1 Therapeutic indications

As a lubricant and artificial tear in dry eye and other ocular irritation syndromes associated with deficient tear or mucous secretion.


Go to top of the page
4.2 Posology and method of administration

Adults, children and the elderly:

One or two drops as required or directed instilled into the conjunctival sac.


Go to top of the page
4.3 Contraindications

Hypersensitivity to dextran 70, hypromellose or to any of the excipients.


Go to top of the page
4.4 Special warnings and precautions for use

• For ocular use only. Not for injection or ingestion.

• Tears Naturale contains benzalkonium chloride which may cause eye irritation and is known to discolour soft contact lenses. Contact with soft contact lenses is to be avoided. Patients should be advised to remove their contact lenses prior to the application of Tears Natural and wait at least 15 minutes before reinsertion.

• If patients experience headache, eye pain, vision changes, irritation of the eyes, persistent redness, or if the condition worsens or persists for more than 3 days, they are to discontinue use and consult their doctor.


Go to top of the page
4.5 Interaction with other medicinal products and other forms of interaction

If more than one topical ophthalmic medicinal product is being used, the medicines must be administered at least 5 minutes apart. Eye ointments should be administered last.


Go to top of the page
4.6 Pregnancy and lactation

Pregnancy

There are no or limited amount of data from the use of Tears Naturale in pregnant women. However, the components dextran 70 and hypromellose exert a surface protective effect and are not pharmacologically active. These components are not expected to be absorbed systemically, to demonstrate any systemic toxicity or to have any effect on reproduction or embryofetal development. Tears Naturale can be used during pregnancy.

Lactation

It is unknown whether dextran 70, hypromellose or any of the components are excreted in human milk. Nonetheless, discontinuation of product use during breast-feeding is not considered necessary. Tears Naturale can be used during breast-feeding.


Go to top of the page
4.7 Effects on ability to drive and use machines

Tears Naturale has no or negligible influence on the ability to drive or use machines. As with any eye drops, temporary blurred vision or other visual disturbances may affect the ability to drive or use machines. If blurred vision occurs at instillation, the patient must wait until the vision clears before driving or using machines.


Go to top of the page
4.8 Undesirable effects

a. Summary of the safety profile

The most frequently occurring adverse reaction during clinical trials was vision blurred.

b. Tabulated list of adverse reactions

The following adverse reactions are classified according to the following convention: very common (≥ 1/10), common (≥ 1/100 to <1/10), uncommon (≥1/1,000 to <1/100), rare (≥1/10,000 to <1/1,000), very rare (<1/10,000), or not known (cannot be estimated from the available data). Within each frequency-grouping, adverse reactions are presented in order of decreasing seriousness. The adverse reactions were obtained from clinical trials and post marketing spontaneous reports.

System Organ Classification

MedDRA Preferred Term (v.12.0)

Immune system disorders

Not known: hypersensitivity

Nervous system disorders

Uncommon: headache

Eye disorders

Very common: vision blurred

Common: dry eye (residual), eyelid disorder, abnormal sensation in eye, foreign body sensation in eyes, ocular discomfort.

Uncommon: photophobia, hypoaesthesia eye, eye pruritus, eye irritation, ocular hyperaemia.

Not known: erythema of eyelid, eye swelling, eye pain, eye discharge, eyelid margin crusting, lacrimation increased.

General disorders and administration site conditions

Uncommon: discomfort (skin)


Go to top of the page
4.9 Overdose

• No case of overdose has been reported.

• An overdose of Tears Naturale can easily be washed out of the eye with lukewarm tap water.


Go to top of the page
5. Pharmacological properties

Go to top of the page
5.1 Pharmacodynamic properties

Pharmacotherapeutic Group: Artificial Tears

ATC Code: S01X A

The combination of Dextran 70 and hypromellose in an aqueous presentation provides a soothing lubricant preparation for the relief of dry eye syndrome associated with deficient tear secretion or deficient mucous.


Go to top of the page
5.2 Pharmacokinetic properties

Not applicable.


Go to top of the page
5.3 Preclinical safety data

There are no preclinical data of relevance to the prescriber which are additional to that already included in other sections of the SPC.


Go to top of the page
6. Pharmaceutical particulars

Go to top of the page
6.1 List of excipients

Benzalkonium chloride

Disodium edetate

Sodium chloride

Potassium chloride

Sodium hydroxide and/or Hydrochloric acid

Purified water


Go to top of the page
6.2 Incompatibilities

None known.


Go to top of the page
6.3 Shelf life

3 years (unopened).

1 month after first opening.


Go to top of the page
6.4 Special precautions for storage

Do not store above 25°C.

Do not refrigerate.

Keep container tightly closed.

Discard one month after opening.


Go to top of the page
6.5 Nature and contents of container

15 ml Drop-Tainer – Low density polyethylene dropper bottle with white polypropylene cap and LDPE tip.


Go to top of the page
6.6 Special precautions for disposal and other handling

None.


Go to top of the page
7. Marketing authorisation holder

Alcon Laboratories (UK) Ltd.

Frimley Business Park,

Frimley, Camberley,

Surrey, GU16 7SR

United Kingdom


Go to top of the page
8. Marketing authorisation number(s)

PL 0649/0031


Go to top of the page
9. Date of first authorisation/renewal of the authorisation

6th July 1979 / 12th September 1995


Go to top of the page
10. Date of revision of the text

29th July 2013



More information about this product

Link to this document from your website: http://www.medicines.org.uk/emc/medicine/74/SPC/


Active Ingredients/Generics